Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice

被引:39
作者
Verreth, W.
De Keyzer, D.
Davey, P. C.
Geeraert, B.
Mertens, A.
Herregods, M-C
Smith, G.
Desjardins, F.
Balligand, J-L
Holvoet, P.
机构
[1] Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Cardiovasc Dis, Div Cardiol, Louvain, Belgium
[3] AstraZeneca, Macclesfield, Cheshire, England
[4] Catholic Univ Louvain, Dept Med, Unit Pharmacol & Therapeut, B-3000 Louvain, Belgium
关键词
atherosclerosis; cholesterol; lipoproteins; metabolic syndrome; obesity; superoxide dismutase;
D O I
10.1038/sj.bjp.0707231
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Our goal was to elucidate mechanisms of the inhibitory effect of rosuvastatin on the accumulation of plaque oxidized low density lipoproteins (oxLDL) and on plaque volume, without lowering cholesterol, in mice with combined leptin and LDL-receptor deficiency (DKO). Experimental approach: Twelve-week old DKO mice were treated with rosuvastatin ( 10 mg kg (-1) day(-1), s. c.) or placebo or no treatment for 12 weeks. The effect on blood variables, aortic plaque volume and composition and gene expression in the aorta and in THP-1 cells was assessed. Key results: Rosuvastatin lowered free fatty acids ( FFA), triglycerides, and increased insulin sensitivity, without affecting cholesterol. Rosuvastatin lowered the plaque volume, inhibited macrophage, lipid and oxLDL accumulation, and decreased the oxLDL- to- LDL ratio of plaques in the aortic arch. It increased superoxide dismutase 1 ( SOD1), CD36, LXR-alpha, ABCA-1 and PPAR-gamma RNA expression in aortic extracts. SOD1 was the strongest inverse correlate of oxLDL. In THP-1 macrophages and foam cells, expression of SOD1 was lower than in THP-1 monocytes. Rosuvastatin restored expression of SOD1 in THP-1 macrophages and foam cells. Conclusions and Implications: Rosuvastatin restored SOD1 expression in THP-1 macrophages and foam cells in vitro and in the aorta of DKO mice. The latter was associated with less oxLDL accumulation within atherosclerotic plaques and inhibition of plaque progression. This effect was obtained at a dose not affecting cholesterol levels but improving insulin sensitivity. SOD1 is a potentially important mediator of the prevention of oxLDL accumulation within atherosclerotic plaques. British Journal of Pharmacology ( 2007).
引用
收藏
页码:347 / 355
页数:9
相关论文
共 39 条
  • [1] Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition
    Argmann, CA
    Edwards, JY
    Sawyez, CG
    O'Neil, CH
    Hegele, RA
    Pickering, JG
    Huff, MW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) : 22212 - 22221
  • [2] A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
    Chawla, A
    Boisvert, WA
    Lee, CH
    Laffitte, BA
    Barak, Y
    Joseph, SB
    Liao, D
    Nagy, L
    Edwards, PA
    Curtiss, LK
    Evans, RM
    Tontonoz, P
    [J]. MOLECULAR CELL, 2001, 7 (01) : 161 - 171
  • [3] Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose
    Costa, A
    Casamitjana, R
    Casals, E
    Alvarez, L
    Morales, J
    Masramón, X
    Hernández, G
    Gomis, R
    Conget, I
    [J]. DIABETIC MEDICINE, 2003, 20 (09) : 743 - 745
  • [4] Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
    Crisby, M
    Nordin-Fredriksson, G
    Shah, PK
    Yano, J
    Zhu, J
    Nilsson, J
    [J]. CIRCULATION, 2001, 103 (07) : 926 - 933
  • [5] Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice
    Didion, SP
    Ryan, MJ
    Didion, LA
    Fegan, PE
    Sigmund, CD
    Faraci, FM
    [J]. CIRCULATION RESEARCH, 2002, 91 (10) : 938 - 944
  • [6] Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells
    Fang, X
    Weintraub, NL
    Rios, CD
    Chappell, DA
    Zwacka, RM
    Engelhardt, JF
    Oberley, LW
    Yan, T
    Heistad, DD
    Spector, AA
    [J]. CIRCULATION RESEARCH, 1998, 82 (12) : 1289 - 1297
  • [7] Vascular protection - Superoxide dismutase isoforms in the vessel wall
    Faraci, FM
    Didion, SP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) : 1367 - 1373
  • [8] Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration
    Fukushima, S
    Coppen, SR
    Varela-Carver, A
    Brindley, G
    Yamahara, K
    Sarathchandra, P
    Yacoub, MH
    Suzuki, K
    [J]. CARDIOVASCULAR RESEARCH, 2006, 69 (02) : 459 - 465
  • [9] Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
    Grip, O
    Janciauskiene, S
    Lindgren, S
    [J]. INFLAMMATION RESEARCH, 2002, 51 (02) : 58 - 62
  • [10] Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome
    Güçlü, F
    Özmen, B
    Hekimsoy, Z
    Kirmaz, C
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (10) : 614 - 618